80 related articles for article (PubMed ID: 25825445)
1. Suppressor of cytokine signaling 1 is a positive regulator of TGF-β-induced prostaglandin production in human follicular dendritic cell-like cells.
Cho W; Kim Y; Kim J; Park S; Park D; Kim BC; Jeoung D; Kim YM; Choe J
J Immunol; 2015 May; 194(9):4287-97. PubMed ID: 25825445
[TBL] [Abstract][Full Text] [Related]
2. Opposing roles of TGF-β in prostaglandin production by human follicular dendritic cell-like cells.
Choe J; Park J; Lee S; Kim YM; Jeoung D
Mol Immunol; 2016 Aug; 76():41-8. PubMed ID: 27344616
[TBL] [Abstract][Full Text] [Related]
3. STAT6 and JAK1 are essential for IL-4-mediated suppression of prostaglandin production in human follicular dendritic cells: opposing roles of phosphorylated and unphosphorylated STAT6.
Cho W; Jeoung DI; Kim YM; Choe J
Int Immunopharmacol; 2012 Apr; 12(4):635-42. PubMed ID: 22406175
[TBL] [Abstract][Full Text] [Related]
4. IL-4 and IL-13 suppress prostaglandins production in human follicular dendritic cells by repressing COX-2 and mPGES-1 expression through JAK1 and STAT6.
Cho W; Kim Y; Jeoung DI; Kim YM; Choe J
Mol Immunol; 2011 Mar; 48(6-7):966-72. PubMed ID: 21277633
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2 stimulates COX-2 expression via mitogen-activated protein kinase p38 but not ERK in human follicular dendritic cell-like cells.
Cho W; Choe J
BMC Immunol; 2020 Apr; 21(1):20. PubMed ID: 32303181
[TBL] [Abstract][Full Text] [Related]
6. Regulation of hen granulosa cell prostaglandin production by transforming growth factors during follicular development: involvement of cyclooxygenase II.
Li J; Simmons DL; Tsang BK
Endocrinology; 1996 Jun; 137(6):2522-9. PubMed ID: 8641206
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of IL-6-induced STAT3 tyrosine phosphorylation by TGF-beta1 is mediated by caspase-dependent and -independent processes.
Wierenga AT; Schuringa JJ; Eggen BJ; Kruijer W; Vellenga E
Leukemia; 2002 Apr; 16(4):675-82. PubMed ID: 11960349
[TBL] [Abstract][Full Text] [Related]
8. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor beta signaling via Ras in mesenchymal cells requires p21-activated kinase 2 for extracellular signal-regulated kinase-dependent transcriptional responses.
Suzuki K; Wilkes MC; Garamszegi N; Edens M; Leof EB
Cancer Res; 2007 Apr; 67(8):3673-82. PubMed ID: 17440079
[TBL] [Abstract][Full Text] [Related]
10. Activation of transforming growth factor-beta1/p38/Smad3 signaling in stromal cells requires reactive oxygen species-mediated MMP-2 activity during bone marrow damage.
Wang L; Clutter S; Benincosa J; Fortney J; Gibson LF
Stem Cells; 2005 Sep; 23(8):1122-34. PubMed ID: 16002781
[TBL] [Abstract][Full Text] [Related]
11. Suppressor of cytokine signaling 1 protects rat pancreatic islets from cytokine-induced apoptosis through Janus kinase/signal transducers and activators of transcription pathway.
Sun Q; Xiang RL; Yang YL; Feng K; Zhang K; Ding WY
Chin Med J (Engl); 2013 Nov; 126(21):4048-53. PubMed ID: 24229672
[TBL] [Abstract][Full Text] [Related]
12. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
[TBL] [Abstract][Full Text] [Related]
13. Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells.
Hayashida T; Decaestecker M; Schnaper HW
FASEB J; 2003 Aug; 17(11):1576-8. PubMed ID: 12824291
[TBL] [Abstract][Full Text] [Related]
14. TGF-beta1 induces COX-2 expression and PGE2 synthesis through MAPK and PI3K pathways in human mesangial cells.
Rodríguez-Barbero A; Dorado F; Velasco S; Pandiella A; Banas B; López-Novoa JM
Kidney Int; 2006 Sep; 70(5):901-9. PubMed ID: 16820791
[TBL] [Abstract][Full Text] [Related]
15. Suppressors of cytokine signaling (SOCS) 1 and SOCS3 interact with and modulate fibroblast growth factor receptor signaling.
Ben-Zvi T; Yayon A; Gertler A; Monsonego-Ornan E
J Cell Sci; 2006 Jan; 119(Pt 2):380-7. PubMed ID: 16410555
[TBL] [Abstract][Full Text] [Related]
16. Positive feedback effect of PGE
Choe J; Yoon Y; Kim J; Jung YJ
Mol Immunol; 2017 Jul; 87():60-66. PubMed ID: 28407559
[TBL] [Abstract][Full Text] [Related]
17. miR-155 modulates TNF-α-inhibited osteogenic differentiation by targeting SOCS1 expression.
Wu T; Xie M; Wang X; Jiang X; Li J; Huang H
Bone; 2012 Sep; 51(3):498-505. PubMed ID: 22634176
[TBL] [Abstract][Full Text] [Related]
18. The IFN-gamma-dependent suppressor of cytokine signaling 1 promoter activity is positively regulated by IFN regulatory factor-1 and Sp1 but repressed by growth factor independence-1b and Krüppel-like factor-4, and it is dysregulated in psoriatic keratinocytes.
Madonna S; Scarponi C; Sestito R; Pallotta S; Cavani A; Albanesi C
J Immunol; 2010 Aug; 185(4):2467-81. PubMed ID: 20644166
[TBL] [Abstract][Full Text] [Related]
19. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
[TBL] [Abstract][Full Text] [Related]
20. SOCS1-negative feedback of STAT1 activation is a key pathway in the dsRNA-induced innate immune response of human keratinocytes.
Dai X; Sayama K; Yamasaki K; Tohyama M; Shirakata Y; Hanakawa Y; Tokumaru S; Yahata Y; Yang L; Yoshimura A; Hashimoto K
J Invest Dermatol; 2006 Jul; 126(7):1574-81. PubMed ID: 16628196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]